









Märkte
/
Aktien
/
nasdaq-amgn
/

Amgen Inc

AMGN

298.240USD

-0.190-0.06%

Trading geöffnet （ET）Kurse um 15 Minuten verzögert

160.54BMarktkapitalisierung

24.25KGV TTM



Amgen Inc

298.240

-0.190-0.06%

Übersicht Unternehmen Finanzen Analyse

Übersicht

Unternehmen

Finanzen

Analyse

mehr Informationen über Amgen Inc Unternehmen

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and improve people's lives. It operates in human therapeutics segment. The Company’s marketed products portfolio includes Aranesp, ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin alfa), KYPROLIS, Repatha (evolocumab), Nplate (romiplostim), Vectibix (panitumumab), MVASI (bevacizumab-awwb), Parsabiv (etelcalcetide), EPOGEN (epoetin alfa), KANJINTI (trastuzumab-anns), BLINCYTO (blinatumomab), Aimovig (erenumab-aooe), EVENITY (romosozumab-aqqg), AMGEVITATM (adalimumab), Sensipar/Mimpara (cinacalcet), NEUPOGEN (filgrastim), IMLYGIC (talimogene laherparepvec), Corlanor (ivabradine), KYPROLIS (carfilzomib), Maridebart cafraglutide, (infliximab-axxq), Evenity, LumaKras, Nplate and XGeva, others.

Amgen Inc Informationen



BörsenkürzelAMGN

Name des UnternehmensAmgen Inc

IPO-datumJun 17, 1983

CEOMr. Robert A. (Bob) Bradway

Anzahl der mitarbeiter28000

WertpapierartOrdinary Share

GeschäftsjahresendeJun 17

AddresseOne Amgen Center Drive

StadtTHOUSAND OAKS

BörseNASDAQ Global Select Consolidated

LandUnited States of America

Postleitzahl91320-1799

Telefon18054471000

Websitehttps://www.amgen.com/

BörsenkürzelAMGN

IPO-datumJun 17, 1983

CEOMr. Robert A. (Bob) Bradway

Führungskräfte von Amgen Inc



Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Robert A. (Bob) Bradway

Chairman of the Board, President, Chief Executive Officer

566.37K

+1.52%

Mr. Esteban Santos

Executive Vice President - Operations

69.05K

+3.06%

Mr. Murdo Gordon

Executive Vice President - Global Commercial Operations

41.70K

+6.10%

Dr. Tyler Jacks

Independent Director

17.19K

+4.94%

Mr. Derek Miller

Senior Vice President - Human Resources

9.93K

+6.57%

Ms. Rachna Khosla

Senior Vice President - Business Development

7.78K

-16.17%

Dr. Brian J. Druker, M.D.

Independent Director

7.57K

+11.97%

Dr. Wanda M. Austin, Ph.D.

Independent Director

7.35K

+12.36%

Ms. Nancy A. Grygiel

Senior Vice President, Chief Compliance Officer

6.04K

-17.35%

Ms. Amy E. Miles

Independent Director

4.84K

+20.06%

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Robert A. (Bob) Bradway

Chairman of the Board, President, Chief Executive Officer

566.37K

+1.52%

Mr. Esteban Santos

Executive Vice President - Operations

69.05K

+3.06%

Mr. Murdo Gordon

Executive Vice President - Global Commercial Operations

41.70K

+6.10%

Dr. Tyler Jacks

Independent Director

17.19K

+4.94%

Mr. Derek Miller

Senior Vice President - Human Resources

9.93K

+6.57%

Ms. Rachna Khosla

Senior Vice President - Business Development

7.78K

-16.17%

Umsatzaufteilung

Währung: USDAktualisiert: Mon, Oct 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Other products

1.69B

18.41%

Prolia

1.12B

12.22%

Repatha

696.00M

7.58%

Otezla

618.00M

6.73%

Enbrel

604.00M

6.58%

Andere

4.45B

48.47%

Nach RegionUSD

Name

Umsatz

Anteil

5.93B

64.59%

ROW

2.32B

25.32%

Nach Geschäftsbereich

Nach Region

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Other products

1.69B

18.41%

Prolia

1.12B

12.22%

Repatha

696.00M

7.58%

Otezla

618.00M

6.73%

Enbrel

604.00M

6.58%

Andere

4.45B

48.47%

Aktionärsstatistik

Aktualisiert: Tue, Aug 19

Aktionäre

Aktionärstypen

Aktionäre

Anteil

The Vanguard Group, Inc.

10.00%

State Street Investment Management (US)

5.45%

BlackRock Institutional Trust Company, N.A.

5.36%

Capital International Investors

3.51%

Capital World Investors

3.13%

Andere

72.54%

Aktionäre

Anteil

The Vanguard Group, Inc.

10.00%

State Street Investment Management (US)

5.45%

BlackRock Institutional Trust Company, N.A.

5.36%

Capital International Investors

3.51%

Capital World Investors

3.13%

Andere

72.54%

Aktionärstypen

Aktionäre

Anteil

Investment Advisor

53.18%

Investment Advisor/Hedge Fund

19.25%

Research Firm

4.97%

Pension Fund

2.20%

Bank and Trust

1.93%

Sovereign Wealth Fund

1.18%

Insurance Company

0.61%

Hedge Fund

0.50%

Individual Investor

0.17%

Andere

16.02%

Institutionelle Beteiligung



Aktualisiert: Wed, Oct 1

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2025Q3

4431

451.46M

83.86%

-5.40M

2025Q2

4453

451.65M

83.89%

+6.94M

2025Q1

4519

453.49M

84.33%

+5.91M

2024Q4

4466

443.40M

82.54%

+89.78K

2024Q3

4316

438.01M

81.42%

-5.13M

2024Q2

4284

437.79M

81.61%

-4.94M

2024Q1

4192

436.25M

81.40%

-5.11M

2023Q4

4150

435.28M

81.36%

+42.25K

2023Q3

3990

429.94M

80.36%

-4.48M

2023Q2

3936

426.14M

79.65%

-4.34M

Aktionärsaktivitäten



Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

The Vanguard Group, Inc.

53.86M

10%

+393.81K

+0.74%

Aug 29, 2025

State Street Investment Management (US)

29.36M

5.45%

+177.03K

+0.61%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

28.83M

5.36%

+326.43K

+1.15%

Jun 30, 2025

Capital International Investors

18.91M

3.51%

+3.78M

+24.95%

Jun 30, 2025

Capital World Investors

16.86M

3.13%

+157.99K

+0.95%

Jun 30, 2025

Geode Capital Management, L.L.C.

13.02M

2.42%

+291.27K

+2.29%

Jun 30, 2025

Charles Schwab Investment Management, Inc.

12.89M

2.4%

+687.74K

+5.63%

Jun 30, 2025

Invesco Capital Management (QQQ Trust)

11.01M

2.04%

-38.88K

-0.35%

Aug 31, 2025

PRIMECAP Management Company

10.63M

1.97%

-1.76M

-14.18%

Jun 30, 2025

Morgan Stanley Smith Barney LLC

8.82M

1.64%

+91.95K

+1.05%

Jun 30, 2025

Verbundene ETFs



Aktualisiert: Tue, Sep 2

Name

Anteil

VanEck Biotech ETF

16.29%

FT Vest DJIA Dogs 10 Target Income ETF

10.17%

ProShares Ultra Nasdaq Biotechnology

7.79%

Amplify Weight Loss Drug & Treatment ETF

7.17%

Invesco Nasdaq Biotechnology ETF

6.93%

iShares Biotechnology ETF

6.85%

Invesco Biotechnology & Genome ETF

5.28%

Invesco Pharmaceuticals ETF

5.16%

Invesco Dow Jones Industrial Average Dividend ETF

5.11%

Invesco QQQ Low Volatility ETF

4.51%

VanEck Biotech ETF

Anteil16.29%

FT Vest DJIA Dogs 10 Target Income ETF

Anteil10.17%

ProShares Ultra Nasdaq Biotechnology

Anteil7.79%

Amplify Weight Loss Drug & Treatment ETF

Anteil7.17%

Invesco Nasdaq Biotechnology ETF

Anteil6.93%

iShares Biotechnology ETF

Anteil6.85%

Invesco Biotechnology & Genome ETF

Anteil5.28%

Invesco Pharmaceuticals ETF

Anteil5.16%

Invesco Dow Jones Industrial Average Dividend ETF

Anteil5.11%

Invesco QQQ Low Volatility ETF

Anteil4.51%

Dividende



In den vergangenen 5 Jahren wurden insgesamt 21.35B USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Dec 10, 2024

AMGN.NB Interim Cash Dividend of gross USD 2.38 paid on Mar 07, 2025 going ex on Feb 14, 2025

Feb 14, 2025

Mar 07, 2025

Feb 14, 2025

Oct 25, 2024

AMGN.NB Final Cash Dividend of gross USD 2.25 paid on Dec 09, 2024 going ex on Nov 18, 2024

Nov 18, 2024

Dec 09, 2024

Nov 18, 2024

Aug 02, 2024

AMGN.NB Interim Cash Dividend of gross USD 2.25 paid on Sep 06, 2024 going ex on Aug 16, 2024

Aug 16, 2024

Sep 06, 2024

Aug 16, 2024

Mar 06, 2024

AMGN.NB Interim Cash Dividend of gross USD 2.25 paid on Jun 07, 2024 going ex on May 16, 2024

May 17, 2024

Jun 07, 2024

May 16, 2024

Dec 12, 2023

AMGN.NB Interim Cash Dividend of gross USD 2.25 paid on Mar 07, 2024 going ex on Feb 15, 2024

Feb 16, 2024

Mar 07, 2024

Feb 15, 2024

Oct 24, 2023

AMGN.NB Final Cash Dividend of gross USD 2.13 paid on Dec 08, 2023 going ex on Nov 16, 2023

Nov 17, 2023

Dec 08, 2023

Nov 16, 2023

Aug 01, 2023

AMGN.NB Interim Cash Dividend of gross USD 2.13 paid on Sep 08, 2023 going ex on Aug 17, 2023

Aug 18, 2023

Sep 08, 2023

Aug 17, 2023

Mar 07, 2023

AMGN.NB Interim Cash Dividend of gross USD 2.13 paid on Jun 08, 2023 going ex on May 17, 2023

May 18, 2023

Jun 08, 2023

May 17, 2023

Dec 12, 2022

AMGN.NB Interim Cash Dividend of gross USD 2.13 paid on Mar 08, 2023 going ex on Feb 14, 2023

Feb 15, 2023

Mar 08, 2023

Feb 14, 2023

Oct 28, 2022

AMGN.NB Final Cash Dividend of gross USD 1.94 paid on Dec 08, 2022 going ex on Nov 16, 2022

Nov 17, 2022

Dec 08, 2022

Nov 16, 2022

Aktien-Split



Datum

Art

Verhältnis

Keine Daten

Datum

Art

Verhältnis

Keine Daten

KeyAI

